参考文献/References:
[1] Bayat AH,Özturan G,Çakr A,et al.Corneal endothelial morphology and anterior segment parameters in children with type 1 diabetes mellitus[J].Turk J Pediatr,2020,62(3):468-473.DOI:10.24953/turkjped.2020.03.014.
[2] 龚莹莹,刘青,邱威,等.糖尿病患者视网膜病变危险因素分析及其对眼前段生物学结构的影响[J].国际眼科杂志,2020,20(7):1216-1221.DOI:10.3980/j.issn.1672-5123.2020.7.22.
[3] 王一鸥,段国平.2型糖尿病患者不同视网膜病变程度下眼表及角膜病变的临床研究[J].国际眼科杂志,2019,19(1):104-106.DOI:10.3980/j.issn.1672-5123.2019.1.23.
[4] 屈超义,王建洲,王欣荣,等.眼轴长度与糖尿病视网膜病变程度的关系[J].眼科新进展,2011,31(11):1082-1083,1086.DOI:10.13389/j.cnki.rao.2011.11.025.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.
[6] 中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014,50(11):851-865.DOI:10.3760/cma.j.issn.0412-4081.2014.11.014.
[7] Jackson TL,Johnston RL,Donachie PH,et al.The Royal College of Ophthalmologists' National Ophthalmology database study of vitreoretinal surgery:report 6,diabetic vitrectomy[J].JAMA Ophthalmol,2016,134(1):79-85; quiz 120.DOI:10.1001/jamaophthalmol.2015.4587.
[8] 向清平,李菲,陈娟,等.血清β2-GPⅠ、Copeptin水平与糖尿病视网膜病变患者视力残疾的关系[J].山东医药,2021,61(25):10-13.DOI:10.3969/j.issn.1002-266X.2021.25.003.
[9] 严良,贾丽丽,李雯,等.2型糖尿病患者眼前段生物结构特征分析[J].贵州医药,2017,41(8):833-835.DOI:10.3969/j.issn.1000-744X.2017.08.015.
[10] Hu Q,Liu G,Deng Q,et al.Intravitreal vascular endothelial growth factor concentration and axial length[J].Retina,2015,35(3):435-439.DOI:10.1097/IAE.0000000000000329.
[11] Man RE,Lamoureux EL,Taouk Y,et al.Axial length,retinal function,and oxygen consumption:a potential mechanism for a lower risk of diabetic retinopathy in longer eyes[J].Invest Ophthalmol Vis Sci,2013,54(12):7691-7698.DOI:10.1167/iovs.13-12412.
[12] 叶青,李超,李斌,等.血清蛋白标志物与糖尿病视网膜病变预后的相关性[J].中华实用诊断与治疗杂志,2019,33(12):1177-1180.DOI:10.13507/j.issn.1674-3474.2019.12.008.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(06):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(06):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(06):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(06):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]